This inventor holds 2 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 1987-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1990
Title: Hirotaka Shinoda: Innovator in Antifungal Compounds
Introduction
Hirotaka Shinoda is a notable inventor based in Kawaguchi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents. With a total of 2 patents to his name, Shinoda's work has the potential to impact the treatment of fungal infections.
Latest Patents
Shinoda's latest patents include innovative compounds known as imidazo[1,5-a]pyrimidine derivatives. The first patent focuses on a novel process for the preparation of these derivatives, which exhibit antifungal activities. The second patent details the use of imidazo[1,5-a]pyrimidine derivatives as antimycotic agents, showcasing their effectiveness against fungal pathogens. These compounds are synthesized through a series of chemical reactions involving α-acylamino-alkylpyrimidines and condensing agents.
Career Highlights
Hirotaka Shinoda is affiliated with Kyorin Pharmaceutical Co., Ltd., where he has been instrumental in advancing research in antifungal treatments. His expertise in medicinal chemistry has led to the development of compounds that could provide new therapeutic options for patients suffering from fungal infections.
Collaborations
Shinoda has collaborated with notable colleagues such as Tsutomu Irikura and Seigo Suzue. Their combined efforts in research and development have contributed to the success of their projects and the advancement of pharmaceutical innovations.
Conclusion
Hirotaka Shinoda's contributions to the field of antifungal compounds highlight his role as an important inventor in the pharmaceutical industry. His innovative work continues to pave the way for new treatments that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
